Volume 13 - Number 4

October - December 2011

HIV Drug Resistance Assessment in the Western Pacific Region. A Systematic Review

Dongbao Yu, Donald Sutherland, Massimo Ghidinelli and Michael Jordan   |Full Article in PDF|

World Health Organization, Western Pacific Regional Office, Manila, The Philippines


Antiretroviral therapy is being rapidly scaled-up in Western Pacific region countries. Prevention and assessment of HIV drug resistance is an essential component of successful global antiretroviral therapy scale-up. We performed a systematic review of public health surveys and HIV drug resistance studies conducted in the low- and middle-income countries in the Western Pacific region. A total of 38 publications assessing HIV drug resistance were reviewed. Studies assessing transmitted drug resistance in recently infected individuals or drug resistance among individuals starting antiretroviral therapy found low rates of HIV drug resistance. Assessments of HIV drug resistance emerging in populations receiving antiretroviral therapy demonstrated variable rates of drug resistance, but suggest an urgent need to support antiretroviral therapy adherence and retention in care, ensure the use of quality assured drugs, and guarantee continuous drug supplies. Additionally, programmatic assessment informed by routine standardized surveillance of transmitted and acquired HIV drug resistance is essential to optimize antiretroviral therapy delivery in the Western Pacific region.

Key Words:

HIV. Drug resistance. Western Pacific.

Contact Us

Permanyer Publications

  • Mallorca, 310 Barcelona, Spain.  08037
Phone / Fax
  • +34 93 207 59 20
  • +34 93 457 66 42
  • permanyer@permanyer.com

     © 2017 Permanyer Publications  -  Legal Notice - Cookies Policy  -  ISSN 1698-6996